Their research gives oncologists a better shot at overcoming the problems of drug resistance, toxicity to patients, and a host of other barriers to consistently achieving successful gene therapy for cancer

Discovery provides potential target for vaccines, treatments

PNNL-OHSU team part of NCI effort to bring proteogenomics to cancer patients

Scientists at Rutgers and other universities build technology that could lead to rapid discovery of new medicines and biomarkers hidden in genomes

Structure of microcompartment’s protein shell could help research in bioenergy, pathogenesis, and biotechnology

First direct evidence that abnormal protein in Parkinson’s disease triggers immune response

A research team set out to explore for the first time whether the protein machinery known as ESCRT-III undergoes dynamic remodeling

PNNL scientist part of Pacific Northwest team that has solved 1,000 protein structures

Previous studies have shown that the type of protein that we inherit from our parents can influence our risk of auto-immune disease and affect how we respond to some forms of cancer treatment

Researchers develop a complete enzymatic platform for making ß-lactone peptides from simple starting materials